The new drugs for Alzheimer's disease: are they cost-effective?
Please note: this is a legacy publication from CPEC (formely PSSRU at LSE).Alzheimer's Disease Society Newsletter
Abstract
The ageing of the world population has been a major achievement for medical science and the economic and social policies of the 20th century. But this success has brought its own challenges. The combined effect of a number of trends - in demography, ge